EUR/USD 1.15421
0.000%
Gold 4390.79
0.013%
Oil 80.932
-0.624%
USD/JPY 159.091
-0.131%
GBP/USD 1.35018
-0.035%
GBP/JPY 214.806
-0.163%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
The French media organization, the National Union of News and Information (NUC), has filed a complaint with the French antitrust regulator regarding Googles (GOOG.O) artificial intelligence business.On August 11, Ma Hui, Vice Minister of the International Department of the Central Committee of the Communist Party of China, met with a delegation led by Yan Ci, President of the European Union Chamber of Commerce in China, in Beijing. The two sides exchanged views on China-EU economic and trade relations and the business environment.On August 11, MMG Limited (01208.HK) announced its interim results for 2026, with revenue increasing by 61% year-on-year to US$4.54 billion, profit after tax increasing by 141% year-on-year to US$1.366 billion, and profit attributable to equity holders of the company increasing by 164% year-on-year to US$897 million. Basic earnings per share were 7.36 US cents. Net cash flow from operating activities increased by 89% to a record high of approximately US$2.234 billion.On August 11, the National Medical Products Administration (NMPA) conditionally approved the marketing of tengotinib tablets (trade name: Jieentai), a Class 1 innovative drug submitted by Jieentai (Nanjing) Technology Co., Ltd., through a priority review and approval process. This drug is indicated for the treatment of adult patients with advanced, metastatic, or unresectable cholangiocarcinoma who have previously received systemic therapy and FGFR inhibitor therapy and have fibroblast growth factor receptor (FGFR) 2 fusions or rearrangements. The approval of this drug provides patients with a new treatment option.A spokesperson for the Qatari Foreign Ministry said: "We hope the international community will put pressure on Israel to push for the implementation of the Gaza Agreement."

NZD/USD Price Analysis: Protects NZ Inflation-Induced Support Break; 0.6140 in Sight

Daniel Rogers

Apr 20, 2023 13:51

 NZD:USD.png

 

During the mid-Asian session on Thursday, NZD/USD bears maintain control at the lowest levels in five weeks while defending New Zealand (NZ) losses caused by inflation near 0.6160. This justifies not only the weaker-than-anticipated New Zealand inflation, but also the recent break of one-month-old horizontal support, which is now immediate resistance, as well as the bearish MACD signals.

 

As measured by the Consumer Price Index (CPI), the Reserve Bank of New Zealand (RBNZ) policy purists were unpleasantly surprised by New Zealand's (NZ) first-quarter (Q1) inflation. Despite this, the Quarter-over-Quarter change in the New Zealand Consumer Price Index (CPI) decreases from 1.7% and 1.4%, respectively, to 1.2%.

 

Following the publication of disappointing data, the NZD/USD pair breached a one-month-old horizontal support level, which is now acting as a barrier near 0.6170. The bearish MACD signals are now directing NZD/USD traders toward a horizontal support level that has been in place for 1.5 months and is located near 0.6140.

 

If the NZD/USD bears remain dominant above 0.6140, the 2023 low of 0.6085 cannot be ruled out.

 

The 200-day simple moving average hurdle of 0.6220 becomes crucial for NZD/USD investors to return.

 

If the NZD/USD pair remains above 0.6220, a run up to the previous weekly high around 0.6315 and then to the monthly high of 0.6386 cannot be ruled out.


Suggestion